Crispina Calsada - Net Worth and Insider Trading
Crispina Calsada Net Worth
The estimated net worth of Crispina Calsada is at least $9,251 dollars as of 2024-12-26. Crispina Calsada is the CFO of Regulus Therapeutics Inc and owns about 5,782 shares of Regulus Therapeutics Inc (RGLS) stock worth over $9,251. Details can be seen in Crispina Calsada's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Crispina Calsada has not made any transactions after 2024-01-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Crispina Calsada
Crispina Calsada Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Crispina Calsada owns 1 companies in total, including Regulus Therapeutics Inc (RGLS) .
Click here to see the complete history of Crispina Calsada’s form 4 insider trades.
Insider Ownership Summary of Crispina Calsada
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RGLS | Regulus Therapeutics Inc | 2024-01-18 | Chief Financial Officer |
Crispina Calsada Latest Holdings Summary
Crispina Calsada currently owns a total of 1 stock. Crispina Calsada owns 5,782 shares of Regulus Therapeutics Inc (RGLS) as of January 18, 2024, with a value of $9,251.
Latest Holdings of Crispina Calsada
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RGLS | Regulus Therapeutics Inc | 2024-01-18 | 5,782 | 1.60 | 9,251 |
Holding Weightings of Crispina Calsada
Crispina Calsada Form 4 Trading Tracker
According to the SEC Form 4 filings, Crispina Calsada has made a total of 1 transactions in Regulus Therapeutics Inc (RGLS) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Regulus Therapeutics Inc is the sale of 5,468 shares on January 18, 2024, which brought Crispina Calsada around $6,507.
Insider Trading History of Crispina Calsada
- 1
Crispina Calsada Trading Performance
Crispina Calsada Ownership Network
Crispina Calsada Owned Company Details
What does Regulus Therapeutics Inc do?
Who are the key executives at Regulus Therapeutics Inc?
Crispina Calsada is the Chief Financial Officer of Regulus Therapeutics Inc. Other key executives at Regulus Therapeutics Inc include Sr. VP & General Counsel Christopher Ray Aker , Chief Operating Officer Joseph P Hagan , and President & Head of R & D Preston Klassen .
Regulus Therapeutics Inc (RGLS) Insider Trades Summary
Over the past 18 months, Crispina Calsada made 1 insider transaction in Regulus Therapeutics Inc (RGLS) with a net sale of 5,468. Other recent insider transactions involving Regulus Therapeutics Inc (RGLS) include a net sale of 14,580 shares made by Joseph P Hagan , a net sale of 5,468 shares made by Christopher Ray Aker , and a net purchase of 4,000 shares made by Kathryn J Collier .
In summary, during the past 3 months, insiders sold 0 shares of Regulus Therapeutics Inc (RGLS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 25,516 shares of Regulus Therapeutics Inc (RGLS) were sold and 4,000 shares were bought by its insiders, resulting in a net sale of 21,516 shares.
Regulus Therapeutics Inc (RGLS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Regulus Therapeutics Inc Insider Transactions
Crispina Calsada Mailing Address
Above is the net worth, insider trading, and ownership report for Crispina Calsada. You might contact Crispina Calsada via mailing address: C/o Ambrx, Inc., 10975 N. Torrey Pines Rd., La Jolla Ca 92037.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
